These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 1689353

  • 1. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ, Melino MR, Staruch MJ, Koprak SL, Fischer PA, Sigal NH.
    J Immunol; 1990 Feb 15; 144(4):1418-24. PubMed ID: 1689353
    [Abstract] [Full Text] [Related]

  • 2. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH.
    J Immunol; 1990 Jan 01; 144(1):251-8. PubMed ID: 1688572
    [Abstract] [Full Text] [Related]

  • 3. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ, Kastner C, Iacovone F, Fischer PA.
    J Pharmacol Exp Ther; 1994 Jan 01; 268(1):32-41. PubMed ID: 7507994
    [Abstract] [Full Text] [Related]

  • 4. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
    Bierer BE, Schreiber SL, Burakoff SJ.
    Eur J Immunol; 1991 Feb 01; 21(2):439-45. PubMed ID: 1705513
    [Abstract] [Full Text] [Related]

  • 5. Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. Analysis in mutant clones of a T cell lymphoma.
    Dumont FJ, Altmeyer A, Kastner C, Fischer PA, Lemon KP, Chung J, Blenis J, Staruch MJ.
    J Immunol; 1994 Feb 01; 152(3):992-1003. PubMed ID: 8301150
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
    Wicker LS, Boltz RC, Matt V, Nichols EA, Peterson LB, Sigal NH.
    Eur J Immunol; 1990 Oct 01; 20(10):2277-83. PubMed ID: 1700753
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells.
    Metcalfe SM, Richards FM.
    Transplantation; 1990 Apr 01; 49(4):798-802. PubMed ID: 1691537
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
    Woogen SD, Turo K, Dieleman LA, Beagley KW, Elson CO.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3274-83. PubMed ID: 8468469
    [Abstract] [Full Text] [Related]

  • 16. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
    Teutsch M, Higer M, Wang D, Wortis HW.
    Int Immunol; 1995 Mar 15; 7(3):381-92. PubMed ID: 7540861
    [Abstract] [Full Text] [Related]

  • 17. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S, Suzuki G, Kawase Y, Takaku F.
    J Immunol; 1987 Sep 15; 139(6):1797-803. PubMed ID: 2442255
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
    Dumont FJ, Staruch MJ, Grammer T, Blenis J, Kastner CA, Rupprecht KM.
    Cell Immunol; 1995 Jun 15; 163(1):70-9. PubMed ID: 7538911
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.